YEON JI JEONG

Learn More
Investigation of the mechanisms of resistance to targeted therapies is essential as resistance acquired during treatment may lead to relapse or refractoriness to the therapy. Our previous study identified the small molecule KRC‑108 as a result of efforts to find an anticancer agent with c‑Met‑inhib-itory activity. In the present study, the changes(More)
  • 1